Abcore is very focused on growing our antibody catalog in 2013, and we are excited to announce the release of 42 new antibodies, focused in the area of cancer, cardiovascular disease, and innate immunity. Releasing antibodies is always exciting, and the feedback we recieve from our customer base is invaluable. We try to release antibodies to meet the research needs of our customers, but we are always looking for feedback or targets which are not represented in the marketplace. Additionally, we also always offer custom antibody production.

Abcore's New Antibodies: